Introducing our Fibroblast-to-Myofibroblast Transition (FMT) Assay

Newcells offers a fast and reliable FMT assay to evaluate the efficacy of anti-fibrotic compounds using high-content imaging. This customisable, high-throughput assay is well suited to compound screening for small molecules targeting lung fibrosis. In the fibrotic lung normal repair processes are defective.